MEDIGOLD, officially known as MEDIGOLD Health, is a leading provider of occupational health services headquartered in Great Britain. Founded in 1997, the company has established a strong presence across the UK, delivering comprehensive health solutions tailored to various industries. Specialising in services such as health assessments, medical screenings, and workplace wellbeing programmes, MEDIGOLD stands out for its commitment to enhancing employee health and productivity. The company has achieved significant milestones, including ISO accreditation, which underscores its dedication to quality and compliance in the healthcare sector. With a robust market position, MEDIGOLD is recognised for its innovative approach to occupational health, helping organisations navigate the complexities of employee wellbeing. Its unique blend of expertise and personalised service continues to set it apart in the competitive landscape of occupational health services.
How does MEDIGOLD's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
MEDIGOLD's score of 27 is higher than 55% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2023, MEDIGOLD reported total carbon emissions of approximately 1,157,900 kg CO2e. This total comprises Scope 1 emissions of about 265,400 kg CO2e, Scope 2 emissions of approximately 161,500 kg CO2e, and Scope 3 emissions amounting to around 731,000 kg CO2e. Within the Scope 3 category, significant contributors include business travel at about 269,900 kg CO2e and employee commuting at approximately 396,000 kg CO2e. Currently, MEDIGOLD has not established specific reduction targets or initiatives, nor are there any climate pledges documented. The absence of reduction targets suggests a need for further commitment to climate action within the organisation. As of now, there is no data cascaded from a parent or related organisation, indicating that all reported emissions data is directly from MEDIGOLD. Overall, while MEDIGOLD has made strides in measuring its carbon footprint, the lack of defined reduction strategies highlights an opportunity for enhanced climate commitments moving forward.
Most of their carbon footprint comes from suppliers and value chain emissions, with Scope 3 emissions accounting for 63% of total emissions under the GHG Protocol, with "Employee Commuting" being the largest emissions source at 54% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
MEDIGOLD has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

